中国发布新规则, 防止网上药品垄断, 以数据误用及“产品购物”为目标。 China issues new rules to prevent monopolies in online pharmaceuticals, targeting data misuse and "product hopping."

中国国务院发布了防止制药业垄断做法的新准则,重点是网上医药企业,禁止滥用数据和算法。 China's State Council issued new guidelines to prevent monopolistic practices in the pharmaceutical industry, focusing on online medicine businesses and prohibiting the misuse of data and algorithms. 药品制造商避免与仿制药竞争. The guidelines also target "product hopping," where drug makers avoid competition from generics. 这些详细的法规旨在促进公平竞争和保护消费者。 These detailed regulations aim to foster fair competition and protect consumers.